Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

scientific article published on 06 December 2019

Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12904-019-0494-6
P932PMC publication ID6898965
P698PubMed publication ID31810437

P50authorJennifer MartinQ44551189
Phillip GoodQ50284017
P2093author name stringPatsy Yates
Alison Haywood
Janet Hardy
Gauri Gogna
Ristan Greer
P2860cites workCannabinoidsQ86852673
A pilot study to assess the validity of the DASS-21 subscales in an outpatient oncology population.Q47926878
Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painQ48131966
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Q21129107
The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].Q24815221
Survey of Australians using cannabis for medical purposesQ24815349
Cannabinoids for Medical UseQ29391539
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyQ29615701
Activities of daily living and costs in nursing homesQ33556253
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trialsQ33850625
The clinical global impressions scale: applying a research tool in clinical practiceQ33894649
Chemical constituents of marijuana: the complex mixture of natural cannabinoidsQ34455944
Cannabidiol in humans-the quest for therapeutic targetsQ34657897
Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).Q34765306
Symptom trends in the last year of life from 1998 to 2010: a cohort study.Q35136945
Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment SystemQ36522629
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of actionQ37285921
Symptom Management and Palliative Care for Patients with Cancer.Q39131507
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participationQ39484634
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectplaceboQ269829
P304page(s)110
P577publication date2019-12-06
P1433published inBMC Palliative CareQ15763886
P1476titleOral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)
P478volume18

Search more.